丙泊酚序贯右美托咪定于全身麻醉苏醒期躁动中的应用

Application of Propofol Sequential Dexmedetomidine in General Anesthesia During Recovery Period of Agitation

目的探究成人全身麻醉苏醒期躁动(EA)患者接受丙泊酚序贯右美托咪定治疗的价值。方法选取成人全身麻醉EA患者50例,时间为2015年10月—2017年10月,按照其治疗方案的差异分组,其中,实验组实施丙泊酚序贯右美托咪定治疗,对照组则实施丙泊酚治疗,对比两组EA患者治疗结果的差异性。结果实验组治疗后的躁动镇静评分、治疗时间、额外镇静药物使用量均少于或低于对照组,差异具有统计学意义(P<0.05);两组的不良反应发生率相比,差异无统计学意义(P>0.05)。结论成人全身麻醉苏醒期躁动患者接受丙泊酚序贯右美托咪定治疗,可取得较高的价值。

Objective To explore the value of propofol sequential dexmedetomidin in patients with EA(awake restlessness)in adult general anesthesia.Methods 50 cases of EA patients with general anesthesia in adult,the time for October 2015 October 2017,grouped according to their treatment differences in the experimental group,the implementation of sequential propofol and dexmedetomidine treatment,the control group was given propofol treatment,the difference between the two groups of EA patients results.Results The restlessness,sedation score,treatment time and the amount of additional sedative drugs in the experimental group were significantly less than those in the control group,the difference was statistically significant(P<0.05),and there was no significant difference between the two groups in the incidence of adverse reactions(P>0.05).Conclusion The patients with agitation in the awakened period of general anesthesia in adult general anesthesia are treated with propofol sequential dexmedetomidin.